Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2022-02-11 4:55 pm Purchase | 13G | KURA ONCOLOGY INC KURA | SUVRETTA CAPITAL MANAGEMENT LLC | 3,572,419 5.4% | 69,000 (+1.97%) | View |
| 2022-02-11 2:03 pm Purchase | 13G | KURA ONCOLOGY INC KURA | STATE STREET CORP STT | 3,378,143 5.08% | 3,378,143 (New Position) | View |
| 2022-02-03 9:43 pm Purchase | 13G | KURA ONCOLOGY INC KURA | Deep Track Capital LP | 3,362,000 5.05% | 3,362,000 (New Position) | View |
| 2022-02-02 7:11 pm Purchase | 13G | KURA ONCOLOGY INC KURA | BlackRock Inc. BLK | 5,095,026 7.7% | 163,070 (+3.31%) | View |
| 2022-01-31 4:39 pm Purchase | 13G | KURA ONCOLOGY INC KURA | EcoR1 Capital LLC | 4,543,447 6.8% | 2,770,410 (+156.25%) | View |
| 2022-01-10 1:26 pm Sale | 13G | KURA ONCOLOGY INC KURA | FMR LLC | 5,582,200 8.387% | -3,533,840 (-38.77%) | View |
| 2021-12-09 4:31 pm Purchase | 13G | KURA ONCOLOGY INC KURA | SUVRETTA CAPITAL MANAGEMENT LLC | 3,503,419 5.3% | 3,503,419 (New Position) | View |
| 2021-12-03 3:07 pm Purchase | 13G | KURA ONCOLOGY INC KURA | Flynn James E | 3,513,756 5.28% | 3,513,756 (New Position) | View |
| 2021-02-16 12:00 pm Sale | 13G | KURA ONCOLOGY INC KURA | EcoR1 Capital LLC | 1,773,037 2.7% | -2,468,916 (-58.20%) | View |
| 2021-02-12 08:09 am Purchase | 13G | KURA ONCOLOGY INC KURA | Avoro Capital Advisors LLC | 4,000,000 6.2% | 4,000,000 (New Position) | View |
| 2021-02-11 4:59 pm Sale | 13G | KURA ONCOLOGY INC KURA | BIOTECHNOLOGY VALUE FUND L P | 1,245,912 1.9% | -1,188,784 (-48.83%) | View |
| 2021-02-08 10:27 am Purchase | 13G | KURA ONCOLOGY INC KURA | FMR LLC | 9,116,040 13.821% | 2,318,838 (+34.11%) | View |
| 2021-02-03 2:29 pm Sale | 13G | KURA ONCOLOGY INC KURA | VICTORY CAPITAL MANAGEMENT INC | 1,836,141 2.78% | -538,445 (-22.68%) | View |
| 2021-01-29 5:23 pm Purchase | 13G | KURA ONCOLOGY INC KURA | BlackRock Inc. BLK | 4,931,956 7.6% | 1,938,204 (+64.74%) | View |
| 2021-01-28 4:41 pm Sale | 13G | KURA ONCOLOGY INC KURA | WILSON TROY EDWARD | 2,190,379 3.3% | -462,076 (-17.42%) | View |
| 2020-03-16 5:23 pm Purchase | 13G | KURA ONCOLOGY INC KURA | BIOTECHNOLOGY VALUE FUND L P | 2,434,696 5.4% | 436,420 (+21.84%) | View |
| 2020-02-14 4:20 pm Sale | 13G | KURA ONCOLOGY INC KURA | GREAT POINT PARTNERS LLC | 853,777 1.88% | -1,915,750 (-69.17%) | View |
| 2020-02-14 2:33 pm Sale | 13G | KURA ONCOLOGY INC KURA | BIOTECHNOLOGY VALUE FUND L P | 1,998,276 4.4% | -776,880 (-27.99%) | View |
| 2020-02-14 2:31 pm Sale | 13G | KURA ONCOLOGY INC KURA | EcoR1 Capital LLC | 4,241,953 9.4% | -1,034,800 (-19.61%) | View |
| 2020-02-07 11:24 am Purchase | 13G | KURA ONCOLOGY INC KURA | FMR LLC | 6,797,202 14.999% | 1,926,324 (+39.55%) | View |